Foley Partner Harold Wegner and Senior Counsel Jim Ewing spoke at the American Conference Institute’s (ACI) 10th Advanced Forum on Biotech Patents in Boston, Massachusetts on September 15, 2008.
Mr. Wegner spoke on Key Biotech Cases to Watch and How They May Impact Your Practice, in his presentation he covered the following:
- Upcoming cases on the Court’s roster and discussed their impact on biotech patent practices.
Mr. Ewing spoke on Navigating the Board of Patent Appeals and Interferences in Light of the KSR decision. Mr. Ewing covered these key points:
- Examining BPAI decisions in light of KSR and the direct affect on the biotechnology industry and its attempt to appeal unfavorable decisions
- Tracking trends post-KSR: what you can expect when appealing your decisions
- The other options: Exploring alternative remedies for protecting your biotech patent outside of the BPAI and the PTO
- Developing an effective biotech patent strategy when the BPAI and the Federal Circuit are in conflict
- Predicting the impact of increase public scrutiny of the BPAI
- Potential changes to the BPAI should the caseload rise, and what they may mean for the patent appeal process
For more information on ACI, please click here.
People
Related Insights
June 13, 2025
Foley Viewpoints
Eighth Circuit Affirms Summary Judgment to Insurer in Dispute with Construction Project Owner Over Lost Rental Income
On Monday, June 9, 2025, the Eighth Circuit Court of Appeals ruled that a Missouri real estate developer could not recover insurance…
June 13, 2025
Foley Viewpoints
Your Company Received an ICE Notice of Inspection — Now What?
“Worksite enforcement operations are going to massively expand,” according to a June 12, 2025, interview[1] with Border Czar Tom Homan….
June 13, 2025
Energy Current
Key Provisions of the One Big Beautiful Bill (H.R.1) Related to Foreign Ownership and Foreign Supply (FEOC)
Applicable Limitations on Tax Credits under Sections 48E, 45Y, and 45X: The below summary describes provisions in the One Big Beautiful…